VIA
MRTX

Vident Investment Advisory’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Vident Investment Advisory’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-37,304
Closed -$2.73M – 665
2019
Q1 		$2.73M Sell
37,304
-1,303
-3% -$95.5K 0.15% 174
2018
Q4 		$1.64M Sell
38,607
-8,974
-19% -$381K 0.09% 299
2018
Q3 		$2.24M Sell
47,581
-3,431
-7% -$162K 0.09% 301
2018
Q2 		$2.52M Buy
+51,012
New +$2.52M 0.1% 277